NCT01678092View on ClinicalTrials.gov

Single Center Study Using Omalizumab in Subjects With Atopic Dermatitis

PHASE1CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

May 31, 2004

Primary Completion Date

December 31, 2006

Study Completion Date

December 31, 2006

Conditions
Atopic Dermatitis
Interventions
BIOLOGICAL

omalizumab

Trial Locations (1)

94022

Stanford University School of Medicine, Stanford

All Listed Sponsors
lead

Stanford University

OTHER

NCT01678092 - Single Center Study Using Omalizumab in Subjects With Atopic Dermatitis | Biotech Hunter | Biotech Hunter